Detection of Nickel Sensitivity Has Increased in North American Patch-Test Patients

Robert L. Rietschel; Joseph F. Fowler; Erin M. Warshaw; Donald Belsito; Vincent A. DeLeo; Howard I. Maibach; James G. Marks; C.G. Toby Mathias; Melanie Pratt; Denis Sasseville; Frances J. Storrs; James S. Taylor; Kathryn A. Zug

Disclosures

Dermatitis. 2008;19(1):16-19. 

In This Article

Results

From 1992 to 2004, 25,626 patients were patch-tested by the NACDG ( Table 1 ). During this time, the ratio of women who were patch-tested to men who were patch-tested remained fairly constant, at 61.4 to 66.3% women to 33.6 to 38.6% men. The data show a steady increase in nickel sensitivity from 14.5% in 1992 to 18.8% in 2004 (p <.0001).

While more males were allergic to nickel in the late group (2001-2004) as compared to the early group (1992-1995), this difference did not quite achieve statistical significance (p = .067). However, females were at 1.1 to 1.2 times more likely to be nickel allergic in the late (2001-2004) group as compared with either the early (1992-1995) group (relative risk [RR], 1.2; 95% confidence interval [CI], 1.10-1.28; p < .0001) or the middle (1996-2000) group (RR, 1.12; 95% CI, 1.04-1.19; p = .0011).

The younger patients in our patch-test clinics were more frequently found to be nickel sensitive than were patients who were 19 years of age or older ( Table 2 and Table 3 ); 11 to 15% of younger males and 19 to 37% of younger females were nickel allergic whereas only 4 to 7% of males and 18 to 24% of females older than 18 years were nickel sensitive. Younger men were 2.33 times more likely to be nickel allergic than were older men (95% CI, 1.80-3.01; p <.0001), and younger women were 1.51 times more likely to be nickel allergic than were older women (95% CI, 1.34- 1.72; p <.0001). Evaluating only those individuals who were allergic to nickel, we found no statistically significant associations between time period for age (≤18 years vs >18 years) for men (p = .5361) or for women (p = .6506)

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....